Vice President and General Manager
at Aldevron
Mark is an experienced business executive with over 20 years at Danaher, having held various roles primarily within the life sciences platform, including key positions at SCIEX and Leica Microsystems. He joined Aldevron in 2021 as transition leader following Danaher’s acquisition of the company in August of that year. After successfully guiding the integration, Mark became VP/GM of mRNA Services at Aldevron in 2022 and later moved into the role of VP CDMO at Danaher in 2024. In this capacity, he is responsible for expanding Aldevron’s mRNA capabilities from drug substance to drug product, delivering a comprehensive sequence-to-vial workflow that includes LNP encapsulation, aseptic fill/finish services and associated analytics.
Got a Question for Mark Wetzel?
Get in touch using the contact form linked here and we'll get back to you shortly.
